Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance


  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Ceftriaxone 1000mg + Tazobactam 125 mg
  Indications :
 

Lower Respiratory Tract Infections

Acute Bacterial Otitis Media

Skin and Skin Structure Infections

Urinary Tract Infections

Uncomplicated Gonorrhea

Pelvic Inflammatory Disease

Bacterial Septicemia

Bone and Joint Infections

Intra-Abdominal Infections

Meningitis

Surgical Prophylaxis

   
  Dosage :
 

Adults : Usual dose: 1.125 to 2.250 grams given once a day (or in equally divided doses twice a day) depending on the type and severity of infection.

Surgical prophylaxis: A single dose of 1.125 gram administered intravenously ½ to 2 hours before surgery.

Children : Skin and skin structure infections: 56.25 to 84.375 mg/kg of Ceftriaxone & Tazobactam given once a day (or in equally divided doses twice a day).

Acute bacterial otitis media: 56.25 mg/kg of Ceftriaxone & Tazobactam given single IM dose.

Serious miscellaneous infections other than meningitis: 56.25 to 84.375 mg/kg of Ceftriaxone & Tazobactam, given in divided doses every 12 hours.

Meningitis: 112.5 mg/kg of Ceftriaxone & Tazobactam given as initial therapeutic dose.

Renally Impaired Patients : Dosage adjustment may be required.

   
  Packing : 10 Vials of 1125 mg
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.